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ABSTRACT
A study of the influence of the anionic detergent 
sodium dodecyl sulfate (SDS), on the enzyme phosphofructo- 
kinase (PFK) has provided information concerning the 
relationship between protein conformation and its 
catalytic activity.
The binding of SDS to the enzyme depends on the 
detergent concentration. It appears that at high SDS 
concentration, the detergent binds at two stages, fast 
(within the first 10 min.), and slow (which lasts for 
approximately 2 hrs.).
Treatment of the enzyme with increasing concentrations 
of SDS brought about a sigmoidal kind of inhibition. This 
inhibition was a result of the detergent binding at 
different sites on the enzyme, causing changes in the 
protein conformation. The number of moles of SDS bound was 
found to be approximately 7+1 moles/mole of PFK.
Several of the known effectors of PFK proved to be 
efficient protectors against inhibition of this enzyme by 
SDS.
The kinetic data obtained suggested that the adenine 
nucleotides compete for the same regulatory site, as 
suggested by data obtained by other approaches. On the 
other hand, citrate binds at a different site from that of
the adenine nucleotides. D-Arabinose 5-phosphate competes 
with D-fructose 6-phosphate (F6P) for the same site.
2,5-Anhydro-D-mannitol 1-phosphate binds the F6P site. 
Fructose 1,6-diphosphate did not protect PFK against 
inhibition by SDS, possibly due to its low affinity for 
the enzyme.
It has been found from the difference spectroscopic 
measurements that the tyrosyl and tryptophyl residues 
change their environment upon the binding of SDS. Also, 
the enzyme might have a nucleotide or oligonucleotide 
associated with its structure.
Circular dichroism studies revealed characteristic 
conformational changes in the enzyme which varied with 
the concentration of SDS used.
The specificity of the F6P site of PFK was studied 
through testing many analogues of the substrate (F6P).
The data obtained showed that: (a) PFK
binds only the furanose tautomer of F6P, (b) the enzyme 
has a restrictive anomeric specificity for the 6-form in 
the phosphorylation process, (c) the C-3 hydroxyl of F6P 
must be present and must have an L-configuration for 
significant activity, (d) the configuration of C-5 must 
have the D-type, (e) hydroxyl is not essential for 
binding or catalysis, (f) either C-l or C-2 hydroxyl must be 
present, and (g) the C-6 hydroxyl must have an anionic
group, with at least one charge for binding. The compounds 
that acted as alternate substrate were: 2,5-anhydro-D- 
mannitol 1-phosphate, (a+3) methyl-D-fruetofuranoside 6- 
phosphate, D-tagatose 6-phosphate, D-tagatose 6-sulfate 
(poor substrate) , and L-sorbose 6-phosphate (poor substrate), 
and D-psicose 6-phosphate (poor substrate). The analogues 
that acted as competitive inhibitors were: D-arabinose
5-phosphate and 2,5-anhydro-D-glucitol 6-phosphate.
SECTION ONE: Sodium Dodecyl
Sulfate-Induced Inactivation of Phosphofructokinase
1
I. INTRODUCTION AND OBJECTIVES
The enzyme, phosphofructokinase (ATP:D-Frucrose-6- 
phosphore 1-phosphotransferase, EC 2.7.1.11), is one of the 
key regulatory enzymes of the glycolytic pathway. It 
catalyzes the reaction:
D-F6P + ATP ^2— v FDP + ADP + H+
Two of the good comprehensive reviews of PFK have been 
published by Bloxham and Lardy (1973), and Mansour (1972). 
Both reviews describe its structural features, principal 
kinetic properties and the proposed mechanisms of action. 
Following are some of the PFK history pertaining to my 
work.
The two most important characteristics of PFK are:
(a) its existence in several molecular forms which appear 
to be a function of pH, enzyme concentration and modifier 
concentration, and (b) the modulation of its activity 
by a large number of modifying ligands. The inhibition of 
PFK by citrate and excess ATP, the activation by FDP, ADP, 
c-AMP and NH4 ions, might be a necessity for its crucial 
position within the cell's metabolic machinery.
Recently, there has been several reports concerning 
the binding of different metabolites by PFK. The results 
obtained jay Kemp (1967, 1969) have indicated that the 
binding of any one of its metabolites could cause
2
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3structural changes leading to changes in the affinity of 
the enzyme for the others. ADP, AMP and c-AMP were bound 
competitively to the same binding site and act as de­
inhibitors by reducing the amount of ATP bound at one or 
the two regulatory sites of ATP. The inhibition by citrate 
is either through direct inhibition of F6P binding or by 
increasing the affinity for ATP which in turn decreases the 
affinity for F6P. All these modifiers were found to be 
bound in 1 mole/90,000 g except ATP which binds in the 
ratio of 3 moles. Lorenson and Mansour (1969) in their binding 
study with sheep heart PFK confirmed the observations of 
Kemp and added that both F6P and FDP were shown to have 
two binding sites for each per 100,000 m wt. of the 
enzyme. Also, he indicated that citrate may act by 
decreasing the affinity for F6P and does not enhance the 
binding for ATP, but may even compete with it for its 
binding site.
Recently, a new character of PFK has been reported by a 
Russian group (Volodina etal., 1971, 1972; Pechenova etaL.,1973). They 
indicated the presence of a nucleotide containing phos­
phorus and pentose firmly bound to PFK, and has an absorp­
tion maximum at 257 nm.
The aim of this work is to study the conformation and 
the binding sites of PFK by investigating the effect of 
SDS on the enzymatic activity, ultraviolet difference
4spectrum and circular dichroism. The binding of different 
ligands by PFK is discussed.
If, as has frequently been postulated, the enzyme 
activity is a function of the protein conformation, then 
changes in the solvent environment which affect activity 
should also affect protein conformation and vice versa.
Many reports by different authors have demonstrated that 
SDS is one of the most effective and convenient ways to 
study the relationship between activity and conformation.
The effect of SDS and other n-alkyl sulfate esters on 
the activity of glutamate dehydrogenase by Maxwell (1962) 
and by Rogers and ttisto (1969,1972) showed that the reaction 
was stimulated at low concentration, inhibited at higher 
concentration and that hydrophobic bonding was of major 
importance in the affinity of these compounds for their 
binding sites. Applying a modified Hill-type equation to 
the data, SDS was found to bind cooperatively with the 
highest relative inhibitory potency. In line with that, 
Pomeranz (1963) found that the inactivation of crystalline 
a-amylase is time and pH dependent. The same effect was 
observed by Torchiniskii and Shipikiter (1963) working with 
aspartate-glutamate transaminase and Mircevova and Siminova 
(1966) with asparatate transcarbamylase.
Koike e t al. (1969) compared the effect of SDS 
on tryptophan oxygenase activity, in presence and in 
absence of some modulators. He concluded that the binding
5of these effectors to allosteric sites mediates conforma­
tional alterations in the quaternary structure, and 
strengthens the subunits interaction. This causes a higher 
concentration of SDS to be a requirement to produce an 
equivalent effect as in absence of the effectors. Additional 
evidence that enhancement in the activity of a- 
chymotypsin was noted at higher SDS concentration was made 
by Gaudin and Viswanatha (1972).
The character and the mechanism by which SDS displays 
its effect on protein structure, was started way back in 
1939. Anson (1939) first demonstrated that a commercial deter­
gent, largely composed of SDS, was a more potent protein 
denaturant than urea or guanidine (very effective at low 
concentration). Since then, many works have been published 
describing concepts and speculations regarding this 
matter. Different techniques have been used, such as, 
ultraviolet difference spectroscopy, hydrodynamic measure­
ments, CD and ORD.
SDS is well known to protect at very low concentration 
some proteins against denaturation through either 
stabilization of ordered structures or organizing the 
disordered ones of the native protein. It is concluded by 
Markus et al. (1964) and Barre et al. (1965) that the 
protection is, in part, based on the formation of detergent 
bridges extending between a group of nonpolar residues and
6positively charged residues (Arg, His and e-NH2 group of 
Lys), located on different loops of the folded structure.
Apparently, proteins either bind large amounts of 
the detergent or none at all (all or none). Probably 
once a small amount is bound, it causes disruption of the 
protein and more is subsequently added (Lundgren et al. 
(1943); Nelson (1971)).
A great deal of work by many investigators (Hill and 
Brigs (1956); Biglow and Sonnenberg (1962); Jirgenson (1962, 
1966); Pitt-Rivers (1968); Tanford (1968); Pish et al. (1970); 
Visser and Blout (1971); Nelson (1971); Steinhardt and 
Reynolds (19.69) led to the following conclusions:
(a) Aromatic side chains (e.g. Try and Tyr) acquire an 
altered environment as a result of SDS binding, 
mostly by their exposure to the solvent. (b) SDS binds
very tightly and maximum binding depends on its ability to 
unfold the protein and the absence of disulfide bonds.
(c) Increasing SDS concentration at a given ionic strength 
will not result in an increase in monomer concentration 
above a specific critical value (critical micellar con­
centration) , above which each monomer will be incorporated 
into a micelle. (d) A wide variety of reduced proteins 
(e.g. BSA, Lysozyme, ovalbumin, Ribonuclease, cyt c, LDH,
Mb, Hb, chymotrypsinogen, 0-lactoglobulin, and P2 
histones, etc.) bind identical amounts of SDS on gm to gm
bases, (0.4 gm SDS/gm protein for one group and 1.4 gm 
SDS/gm protein for the other). PFK was found to be of the
7second group by Igou (1973). This binding is nonspecific 
and produces a cooperative conformational change, which 
leads to a uniform structure (rode - like shape) in the 
complexed state, at higher SDS concentration. (e) The 
hydrophobic interior and crevices are go6d attractive 
sites in which nonpolar tails can be buried. This leads 
to conformational changes and creates new helical regions 
in many cases. Original helices have poor affinity for 
the detergent tail.
The work described in this dissertation includes a 
study of the effect of SDS on PFK activity and 
of the conformational change induced by its binding.
Two of the most useful analytical methods in 
detecting conformational changes are spectropolarimetry 
(ORD and CD) and ultraviolet difference spectroscopy.
Circular dichroism (CD) results when an asymmetric 
chromophore absorbs right hand and left hand circularly 
polarized light unequally. The CD spectrum is a result 
of measuring the absorbed light over a spectrum of wave­
lengths. Many authors (Dratz, 1966), (Freisheim and 
D'souza, 1971), (Hirata et al., 1971), (Igou et al. 1974) 
have utilized this technique successfully in observing 
conformational changes for several proteins and peptide 
chains.
Ultraviolet difference spectroscopy of proteins is 
based on the UV absorption in the region 250-310 nm due to
8the electronic excitation of their aromatic side chains, 
tyr, try, and to some extent phe. The perturbations in 
the absorption spectra of these side chains give informa­
tion concerning their environment and location, which is 
brought about by a change in the pH, temperature, solvent 
composition, etc. As a result of chromophore perturbation, 
the spectrum will be altered and shifted along the wave­
length axis, to a longer (red shift) or shorter (blue 
shift) wavelength. This is usually accompanied by an 
increase or decrease in intensity of the spectrum. The 
red shift of a chromophore might be interpreted as an 
increase in the polarizability in the immediate environ­
ment, such as that produced by absorbed hydrophobic tails 
on these chromophores. The blue shift might be explained 
as due to the exposure of buried chromophores to the 
aqueous solvent. Difference spectroscopy is characterized 
by its wide applicability to many problems and has been 
used to determine: the thermodynamic parameters for
thermal denturation; specific interactions between enzymes 
and their substrates? binding of small molecules and large 
ions • enzyme actions ? and reporter groups. For more 
detailed information reference should be made to several 
recent reviews, (Scheraga, 1961), (Wetlaufer, 1962), 
(Herskovits and Laskowski, 1967), (Donovan, 1969) and 
(Steinhardt and Reynold, 1969).
9The research reported in this dissertation has a dual 
purpose: (a) to study the structure function relationship
of PFK; and (b) to provide information on the nature of 
SDS binding to PFK.
II. MATERIALS AND METHODS
Reagents
Adenosine triphosphate (ATP), adenosine diphosphate 
(ADP), adenosine monophosphate (AMP), adenosine 3,5-cyclic 
monophosphate fc>AMP), 6-nicotinamide adenine dinucleotide 
reduced form (NADH), D-fructose 6-phosphate (F6P), D- 
fructose 1,6-diphosphate (FDP), phosphoenol pyruvate 
tricyclohexylamine salt (PEP) , dithiothreitol (DTT), 
bovine serum albumin (BSA) , aldolase, a-glycerophosphate 
dehydrogenase-triosephosphate isomerase (a-GDH-TPI), 
lactic dehydrogenase (LDH), pyruvate kinase (PK), and 
ethylenediamine tetraacetate (EDTA) were purchased from 
Sigma Chemical Company. Ammonium sulfate (enzyme grade), 
potassium chloride, magnesium sulfate and citrate were 
purchased from "Baker Analyzed" Reagent ; imidazole from 
Aldrich Chemical Company, Inc.; 2,5-anhydro D-mannitol 1- 
phosphate synthesized by Koerner et al. (1974); tris (hydroxyl 
methyl) aminomethane (tris-ultra pure) and lauryl sodium 
sulfate (SDS-ultra pure) from Schwarz/Mann Company.
Phosphofructokinase (PFK) was prepared from young 
rabbit muscle by the method of Ling et al^ . (1965) . The 
crystallization step with ATP was omitted to avoid the 
effect of this nucleotide on the kinetic characteristics 
of the enzyme. Instead, PFK was passed through G-200
10
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sephadex column to insure highly purified sample,
particularly for structural work.
I stored PFK as a concentrated solution (12.0 mg/ml)
in 0.1 M KH^PO^ buffer, pH 8.0, containing 0.2 mM EDTA at
4°C, and I noticed that the yield and the specific
activity were usually high, so long as the rabbit was young
(= 3 months old).
In one of the experiments, the auxiliary enzymes,
namely aldolase, a-glycerophosphate dehydrogenase-
triosephosphate isomerase were dialyzed ’to eliminate all 
+NH^ , in which it is usually suspended. The dialysis was 
for 36 hrs. against three changes of 50 mM Tris7Cl, pH 8.0, 
containing 20 mM EDTA.
Enzyme Assay
In most of my experiments, I assayed the enzyme 
activity by the coupled procedure depicted in Figure 1A, 
which depends on the rate of ADP appearance. The pro­
cedure is a modification of glutamine synthetase assay by 
Wellner et al. (1966). The assay mixture contained 50 mM 
Tris-Cl, pH 7.8, 4 mM MgSO 4 , 50 mM KC1, 0.2 mM EDTA,
3 mM DTT, 3 mM PEP, 1 mM ATP, 1 mM F6P, 0.16 mM NADH. The 
auxiliary enzymes pyruvate kinase and lactic dehydrogenase 
were present in large excess to avoid being limiting 
(■ 30 units each). An appropriate amount of PFK (0.06 
Ug/ml) was added to initiate the reaction.
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In few experiments which will be indicated later on, 
I used the coupled procedure described by Ling et al.
(1966), which depends on FDP assay as shown in Figure IB.
To test the effect of SDS on PFK, this enzyme was 
incubated at 4°C for 2 hrs. in 0.05 M Tris-phosphate, pH 
8.0, 1 mM EDTA, 3 mM DTT, and the predetermined concentra­
tions of SDS, in presence or in absence of different 
effectors. In the case of using an effector in the 
incubation mixture, it was added before adding SDS. I 
noticed the formation of micelle aggregate for most of the 
SDS concentrations I have used when plain water was the 
solvent. Therefore, I prepared SDS solutions in the same
buffer described above to avoid micellar formation. PFK
—3concentration in the incubation mixture was 2.4x10 mg/ml. 
Final concentrations of SDS in the incubation mixtures 
ranged from 1x10 M to a concentration that caused 
complete inhibition of PFK activity.
The enzymatic activity was assayed by monitoring the 
change in absorbance of NADH at 340 nm, using a Gilford 
recording spectrophotometer. I set the full chart width 
for one inch per minute. An enzyme unit was defined as 
the amount which catalyzes the conversion of 1 ymole of 
F6P to FDP per minute at pH 7.8 and 28°C.
In most of the experiments I have done in presence 
and absence of different effectors, enzyme reaction 
velocities were computed as the change in OD per minute
13
and converted to percentage of original activity (control) 
by the equations
vi—  x 100 = % of original activity (1)
where,
v^ = velocity of the enzyme in presence of 
SDS (OD/min.) ,
and
v = velocity of the native enzyme in absence 
of SDS (OD/min.) .
Difference Spectroscopy Measurements
Experimental considerations:
1. The difference spectral studies were carried out 
with the aid of a Cary Model 14 Spectrophotometer, and the 
very small difference spectrum was recorded using an 
expanded scale.(0.0 - 0.1 absorbance unit) slide wire.
2. The instrument was allowed time to warm up and 
stabilized to avoid amplifier drift.
3. Scaning speed was slow enough to prevent "over­
ride" on the absorption of the peaks.
4. A flat baseline in the region 350-310 nm is an 
indication of absence of turbidity, since nonconjugated
Figure 1
This figure indicates the principle and the difference 
between the two coupled assay procedures. Figure 1A depends 
on the coupled assay of ADP by the two auxiliary enzymes 
pyruvate kinase (PK) and lactic dehydrogenase (LDH). while 
Figure IB shows the principle of the method of Ling et al. 
(1966), in which the product FDP was subjected to the 
auxiliary enzymes namely aldolase, triosephosphate isomerase 
and a-glycerolphosphate dehydrogenase. In both cases the 
decrease in NADH absorbance was measured at 340 nm.
14
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proteins are transparent in this region (the tyrosyl 
residue starts to absorb at 310 nm) .
5. A suitable protein concentration may be chosen by 
plotting the height of the difference spectrum of a series 
of sample and reference solutions having different protein 
concentrations against the protein concentration to get a 
straight line passing through the origin (Beer's Law). The 
working protein concentration is any one on the linear 
portion of the curve.
6. An air-air and/or buffer-buffer baseline (zero 
line) is obtained for the instrument and/or instrument plus 
cells. This baseline is adjusted to zero throughout the 
wavelength range of interest, by using a set of potentio­
meters called "multipots". Their function is to adjust 
the baseline as a function of wavelength.
7. Well-matched cells should not produce deviations 
from the baseline in the experimental absorption region
of the spectrum of more than +0.002 absorbance unit, other­
wise, the baseline must be readjusted.
8. Exact volumetric manipulations are of great 
importance. Therefore, errors inherent in pipetting, 
volumetric adjustment, and transfer of solutions must be 
reduced to a minimum.
9. Difference spectral measurements should be made 
soon after the solutions are prepared (10-30 min.), since 
standing might cause slow aggregation and turbidity.
17
Absorption cells
It was very convenient to use the double compartment 
"tandem cells" of Herskovits and Laskowski (1962),(Figure 
2). The cells were designed to subtract the solvent and 
the protein contribution to the difference spectra, which 
usually occurs by using one compartment cells.
The front part of the cell compartment containing the 
protein plus the perturbant (SDS) is filled with buffer. 
This is balanced by placing the perturbant with buffer in 
the "blank" compartment of the reference cell. The 
solution compartment of this cell is reserved for the 
protein solution. The positioning of the filled cells in 
the instrument should be such that the blank compartments 
face the source of radiation, so that the light beams 
enter the blank-containing sections of the cells first 
(Figure 2).
The amount of buffer, SDS, and protein should be the 
same in both cells. Any minor difference,particularly 
in the protein concentration, causes positive or negative 
absorption relative to the baseline. To correct for that, 
the solutions should be matched either by patient dilution 
of the more concentrated solution or by adding more 
protein to the more dilute one.
Difference spectral measurements
The baseline was first adjusted using the "multipot" 
knobs, to get a satisfactory zero line in absence and in
Figure 2
The tandem double-compartment cells.
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presence of the cell and the buffer. The instrument 
adjustments were at 5 period selector to lower the noise
s
without losing sensitivity. The chart speed was set at 
xlO (which is considerably slow), the marker at 100 A°, and 
the scanning was carried out in the region from 330-220 nm.
Final concentration of the solutions in the 3 ml 
tandem cell compartment was 50 mM Tris-phosphate, pH 8.0,
1 mM EDTA, 0.1% PFK as one equivalent. The solutions were 
mixed by inversion with parafilm "M" over the top of the 
cell windows. The baseline was established again by 
equalizing the protein concentration in both cells.
Aliquots of SDS were then added to each cell in equivalents, 
the largest volume added did not exceed 1/100 of the total 
cell volume. Equal volumes of the buffer were then added 
to the corresponding compartments. The spectrum was then 
recorded after each detergent addition. SDS aliquots 
used were 4, 6, 10, 20, and 50 equivalents prepared in the 
same previously described buffer to avoid micellar forma­
tion (Figure 3).
A second part was to study the difference spectrum 
induced by binding the substrate F6P to the enzyme at 1,
3, and 5 mM. The protocol of the experiment was exactly 
similar to the one described above. The only difference 
was using F6P instead of SDS. Following the recording of 
the spectrum of the three substrate concentrations, 50 
equivalents of SDS were added and the spectrum was recorded.
Figure 3
A diagram to show the tandem double-compartment cell 
and the composition of the solutions used. The cells 
contained 50 mM Tris-phosphate buffer, pH 8.0, 0.1 mM 
EDTA, 1 equivalent of PFK, and 4, 6, 10, 20, and 50 
equivalents of SDS.
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Chymotrypsin Digestion of PFK
Purified PFK was reduced, alkylated, and dialyzed 
against 0.5% (NH4) HC03, According to Hirs Method (1967). 
Digestion of PFK suspension by chymotrypsin (2% by wt. of 
PFK used) was carried out at pH 8.0 for 4 hrs. The re­
action was then stopped by lowering the pH to pH 2.0 with 
formic acid. The digested enzyme was applied to an ion 
exchange column (Dowex 50-x8), column was developed with 
gradient of 0.2 M pyridine, pH 2.0 to 2.0 M pyridine, 
pH 5.0. The pH of the gradient was adjusted with acetic 
acid.
This experiment was done with the help of Dr.,E. 
Blakeney.
Circular Dichroism
CD was carried out on a Durrum-Jasco J-20 recording
spectropolarimeter, calibrated on the basis of [0] = 7260 
2deg cm /dmole for d-10-camphorsulfonic acid in water 
(Cassim and Yang, 1970). The calibration factor F was 
used in Equation (2) , for calculating the mean residue 
ellipticity.
24
where,
2
[0] = mean residue ellipticity in deg cm /dmole
F = calibration factor for CD
E = experimental chart reading in cm
B = blank or baseline value in cm
S = sensitivity in m°/cm
m = mean residue molecular weight in g/mole
c = concentration of solute in mg/ml
L = length of cell path in mm
The mean residue molecular weight used for PFK was
110. Circular silica cells of 1.0 and 10 mm were used 
depending on the protein concentration. Solutions were 
made up to test the effect of varying SDS concentrations 
on the CD of PFK under the following conditions: (a) At
1 mg/ml PFK, 50 mM Tris-phosphate, pH 8.0, 1 mM EDTA. SDS 
solution was prepared in high concentration in the same 
buffer and aliquots of 10, 20, 30, 50 and 100 equivalents 
(in microliter volumes) were taken and introduced into the 
circular cells using Hamilton microliter syringe to attain 
the predetermined SDS concentrations. (b) At 0.2 mg/ml 
PFK, 50 mM Tris-phosphate, pH 8.0, 1 mM EDTA. SDS solution 
was added in 20, 30, 50, 100 and 150 equivalents relative 
to PFK. (c) At 0.02 mg/ml PFK, 50 mM Tris-phosphate, pH
25
8.0, 1 mM EDTA. SDS were taken in 4 r 6, 10, 20, 30, 50, 
and 100 equivalents.
The volume of SDS did not exceed 1/50 of the total 
sample volume. A control was made at zero SDS concentra­
tion. Sample scannings were obtained at 218 nm at which 
the change in a-, 8-, and random coil structures are clear, 
and also in the aromatic region of the spectrum. Blanks 
were scanned periodically in the same wavelength regions.
III. RESULTS 
Effect of Time of Incubation of SDS with PFK
A preliminary experiment to test the effect of
increasing concentrations of SDS on PFK activity indicated
that the loss of the catalytic activity is time dependent.
-6 —5Figure 4 demonstrates this time effect at 2x10 , 2.5x10 ,
—5and 4x10 M SDS for 2 hrs. incubation period. The 
experimental conditions were as described under"Materials 
and Methods". The activity was measured immediately after 
incubation, then after 10, 20, 30, 60 and 120 minutes 
incubation periods. It is clear that more than 50% of
the activity was lost within the first 10 minutes at
-5 -52.5x10 M and 4x10 M SDS. Complete loss of the
—5activity was observed within 2 hr s. at 4x10 M SDS, while
-5 . .at 2.5x10 M SDS the loss was 60% of the original
activity. On the other hand, there was slight enhancement
of the activity at 2x10""^ M SDS relative to the control in
absence of SDS. The conclusion of this experiment is that
the inactivation occurs on two stages: the first one
involves rapid loss of the activity within the first 10
minutes and the second is relatively slow and continues
until the reaction reaches equilibrium within 2 hrs. The
extent of inactivation is dependent on SDS concentrations
at a fixed time.
Figure 4
Activity of PFK using three different SDS concentra-
-6 —5 -5
tions 2x10 , 2.5x10 , and 4x10 M as a function of the
incubation time. Each incubation mixture contained 50 mM
Tris-phosphate, pH 8.0, 3 mM DTT, 1 mM EDTA, 2.4xl0-3
mg/ml PFK, and the corresponding SDS concentrations. The
incubation was carried out in ice at 4°C. The assay
mixture (1 ml) contained 50 mM Tris-Cl, pH 7.8, 4 mM MgSO^,
50 mM KC1, 0.2 mM EDTA, 3 mM DTT, 1 mM ATP, 1 mM f 6P,
3 mM PEP, 20 units of the auxiliary enzymes pyruvate
kinase plus lactic dehydrogenase, 0.06 ug PFK from the
treated SDS incubation mixtures, and 0.16 mM NADH.
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Inactivation of PFK as a Function of Increasing SDS 
Concentrations
Figure 5 indicates the inactivation of PFK as a
function of SDS; PFK was preincubated for two hr s. before
assaying its activity. Incubation and assay mixtures
were as described under Materials and Methods and in
Figure 4. It can be seen that the percentage of the
reaction velocity in the presence of SDS in the reaction
mixture to that in its absence (v^/v x 100) is slightly
increasing at low SDS concentrations. At SDS concentra-
“6tions greater than 5x10 M, the activity decreases
progressively until complete inhibition is reached at
—5 -54x10 M. An SDS concentration of 2.25x10 M is re­
quired to effect a 50% reduction of the enzymatic 
activity. The observed loss of enzymatic activity seems 
to be a sigmoidal inhibition under this condition. This 
tends to indicate that the activity exhibited by PFK in 
the presence of SDS is due to an oligomeric form of the
enzyme and that PFK is not disrupted to the monomeric
—5form by SDS concentration up to 4x10 M.
PFK Inactivation as a Function of SDS Concentration in the 
Presence of Bovine Serum Albumin
Bovine serum albumin used to be one of the constituents 
of the dilution mixture (stock solution), to stabilize
Figure 5
Inactivation of PFK as a function of SDS concentration. 
PFK was preincubated for 2 hrs. prior to the assay. Re­
actants and conditions of incubation and assay were as 
described under "Materials and Methods" and Figure 4.
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the enzyme during its assay. I was faced with the problem 
of whether to include it as usual or not in the incubation 
mixture with SDS. I carried out the experiment shown in 
Figure 6 in the presence and in the absence of 0.01% BSA 
in the incubation mixtures as described in Figure 3 to 
resolve this problem. From Figure 6 it is clear that 
bovine serum albumin interferes with PFK inactivation and 
acts as a protector against SDS inactivation for PFK. 
Complete inhibition occurred at about 70 yM SDS compared 
to 40 yM in its absence. This indicates a protecting 
effect of bovine serum albumin on PFK against the action 
of SDS. This is probably brought about by the binding of 
part of the added SDS by the albumin or binding the 
albumin by PFK. Because of this complicating effect, I 
excluded the bovine serum albumin from all the experiments 
with SDS. Reactants and conditions were as described in 
Figure 5. It is noticed that under these experimental 
conditions, the incubation time has very little effect on 
the inactivation after the first 10 minutes and could be 
neglected.
Inactivation of PFK as a Function of SDS Concentration in 
Presence of Some Nucleotide Effectors
Figure 7 illustrates the effect of the nucleotides, 
AMP, ADP, c-AMP, ATP, and MgATP on the SDS-induced in­
activation of the native enzyme. All nucleotides were
Figure 6
PFK inactivation as a function of SDS concentration 
in presence of 0.01% BSA in the incubation mixture. BSA 
was added to PFK, then SDS, and incubated for 2 hrs. prior 
to the assay. Incubation and assay condition as in 
Figure 5.
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Figure 7
The protection of PFK against SDS-induced inactiva­
tion by incubating the native enzyme with 1 mM of ATP, .AMP, 
c-AMP, MgATP (1:4), and ADP separately. Incubation time 
was 2 hrs. The protector was added to the enzyme before 
adding SDS. Experimental conditions were as described in 
Figure 6.
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present in the incubation mixture at 1 mM concentration.
It is clear that all of them protect PFK against the 
action of SDS, i.e., a higher concentration is required 
to bring about a 50% inhibition equivalent to that ob­
served in the absence of these nucleotides. From some 
preliminary experiments the sequence of addition and the 
time effect were not significant. The incubation time 
was 2 hrs. The Figure shows that the percentage of 
activity and the protection by AMP and ATP separately are 
identical. The same thing can be said for c-AMP and MgATP, 
except that they offer much more protection than AMP or 
ATP. ADP offers the highest protection of all of them.
A 50% inactivation for the control with no effectors 
and in presence of AMP or ATP, c-AMP or MgATP, and ADP as 
protectors was obtained at 25, 41, 55, and 83 yM SDS, 
respectively. A complete inactivation for the same con­
secutive group was shown at 40, 60, 71, and 110 yM SDS. It 
should be noted that all curves exhibited a sigmoidal 
profile.
Of particular significance is the control point at
-5which there is complete inhibition (4x10 M) . This same 
concentration of SDS in presence of ATP or AMP, c-AMP or 
MgATP, and ADP produces 55, 93 and 116% activity, 
respectively.
The conclusion from this experiment is that AMP,
MgATP, and c-AMP exert a protective effect against SDS
38
action although to varying extents. ADP offers the highest 
protection relative to other nucleotides.
Protection Against SDS-induced Inactivation of PFK by Its 
Modulators and a Substrate Analogue
Figure 8 provides a comparison of the protection 
against SDS-induced inactivation affected by incubating 
the native enzyme with 1 mM F6P, 1 mM FDP, and 1 or 10 mM 
2,5-anhydro-D-mannitol 1-phosphate, separately. It is 
clear that FDP and 2,5-anhydro-D-mannitol 1-phosphate, at 
1 mM, each has largely no effect on protection compared 
to the control experiment in absence of any effector. 
Increasing 2,5-anhydro-D-mannitol 1-phosphate concentra­
tion to 10 mM induces some protection, although it is 
still low compared to the protective effect of F6P.
A 50% inactivation was observed at the following 
concentrations of SDS and of effectors: the control, FDP
(1 mM) , and 2,5-anhydro-D-mannitol 1-phosphate (1 mM) at 
about 27 yM SDS; for 2,5-anhydro-D-mannitol 1-phosphate 
(10 mM) at 39 yM SDS; and for F6P (1 mM) at 64 yM SDS. 
Comparing the inhibitory concentrations of SDS in the 
presence and in the absence of F6P, it is obvious that 
approximately double the inhibitory concentration of the 
control was required to inhibit PFK in presence of 
F6P (1 mM).
Figure 8
The inactivation of PFK by SDS in presence of the 
product (FDP), the substrate (F6P), and the substrate 
analogue 2,5-anhydro-D-mannitol 1-phosphate, separately. 
Reactants and conditions were as described in Figure 7.
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The Effect of D-Arabinose 5-phosphate on the SDS-Induced
Inactivation of PFK
It has previously been shown that D-arabinose 5-
phosphate competitively inhibits the catalytic activity of
PFK (Koener et al^ (1974). It can be seen that increasing
D-arabinose 5-phosphate concentrations inhibit the catalytic
activity in absence of SDS (Figure 9). In its presence,
increasing D-arabinose 5-phosphate concentrations protect
against the induced inactivation by SDS. If there is no
protection, the two curves would appear to be parallel with
the one in presence of both SDS and D-arabinose 5-phosphate
being of lower activity due to their combined inhibitory
effects. As the concentration of D-arabinose 5-phosphate
reaches 17 mM protection begins to appear against SDS-
induced inactivation. The incubation time was one hour
prior to the assay. The F6P concentration in the assay
mixture was relatively low, namely 0.02 mM, so as to cause
the D-arabinose 5-phosphate inhibition to be more
-5pronounced. The 2.5x10 M SDS concentration used 
represents about 40% activity of the control curve in 
Figure 5. Reactants and conditions were as described in 
Figure 8.
Figure 9
The protection against SDS-induced inactivation by 
increasing D-arabinose 5-P (competitive inhibitor) con­
centration in the incubation mixture. Incubation time was 
1 hour and the F6P concentration was 0.02 mM. Other 
reactants and conditions were as previously described in 
Figure 8.
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The Lack of Protective Effect of Citrate Upon the SDS-
induced Inactivation of PFK
Citrate is very well known as a potent inhibitor for 
PFK (Abrahams and Younathan, 1973) . It can be seen from 
Figure 10 that citrate has no protective effect as ob­
served with D-arabinose 5-phosphate (Figure 9).
Increasing concentrations of citrate inhibit the catalytic 
activity in the absence and in the presence of SDS in a 
parallel manner. This indicates that citrate affords no 
protection against the inactivating effect of SDS, and 
their effects are additive. The incubation mixture here 
is the same as previously described in Figure 9, while the 
assay procedure is completely different. The method of 
Ling et al. (1966) was used and the auxiliary enzymes were 
dialyzed. The assay mixture contains 50 mM imidazole-HCl 
buffer (pH 7.0), 0.5 mM F6P, 1 mM ATP, 1 mM NH4C1, 4 mM 
MgSO^, 0.2 mM EDTA, 3 mM DTT, 0.16 mM NADH, auxiliary 
enzymes in large excess, and PFK in an appropriate amount. 
The reason for using this assay method and pH 7.0 is to 
observe the inhibitory effect of citrate more accurately.
Incubation time was 1 hour prior to the assay, and citrate
-5was added before SDS. 2.5x10 M of SDS was used, which 
gives about 40% activity on the control curve (Figure 4).
Figure 10
Effect of citrate on the SDS-induced inactivation of 
PFK. The assay method of Ling et al. (1966) was used.
The assay mixture contains 50 mM Imidazole-HCl buffer 
(pH 7.0) , 0.5 mM F6P, 1 mM ATP, 1 mM NH4C1, 4 mM MgSC>4,
0.2 mM EDTA, 3 mM DTT, 0.16 mM NADH, auxiliary enzymes 
(aldolase, triosphosphate isomerase, a-glycerolphosphate 
dehydrogenase) in excess, and PFK in an appropriate amount. 
The enzyme was incubated for 1 hour with increasing 
concentrations of citrate and a fixed amount of SDS 
(2.5xl0“5 M).
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The Effect of SDS on the Sigmoidal Kinetics of PFK
It is known that an inhibitory concentration of ATP 
will increase the sigmoidicity of the PFK curve with 
respect to F6P while activators will decrease it. To 
produce the sigmoidal curve for the enzyme, it is 
necessary to know this inhibitory level of ATP. As shown 
in Figure 11, PFK inhibition by ATP is also a function of 
the Nh £ concentration in the assay mixture. This experi­
ment was carried out under the same experimental conditions 
of Figure 10 except for the use of 0.1 mM F6P, and three 
different NH^ concentrations (0.1, 1, and 2 mM). A con­
centration of 0.5 mM ATP was found to be sufficient to 
produce the sigmoidal curve as shown in Figure 12.
Figure 12 depicts the sigmoidal kinetics of PFK as a
function of F6P concentration at 2.0xl0-6 and 2.5xl0~5 M
SDS concentrations. The incubation time was 1 hour. The
assay mixture contained 0.1 mM NH4C1, 0.5 mM ATP and
imidazole-HCl buffer (pH 7.0). It is clear that the
incubation of PFK with SDS at low concentration (2.0xl0-^
-5M) or higher concentration (2.5x10 M) did not affect the 
sigmoidicity relative to the control curve in the absence 
of SDS.
Figure 11
Activity of PFK as a function of ATP concentration, 
at 0.1 mM F6Pf 0.1, 1, and 2 mM NH^. Each reaction 
mixture contained 50 mM imidazole-HCl buffer (pH 7.0),
4 mM MgSO^, 0.2 mM EDTA, 3 mM DTT, 0.16 mM NADH, excess 
dialyzed auxiliary enzymes, and an appropriate amount of 
PFK. Other reactants and conditions were as described 
under "Materials and Methods" and Figure 10.
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Figure 12
PFK activity as a function of F6P concentration in the
-6 -5presence of 2.0x10 and 2.5x10 M SDS in the incubation
mixture. The enzyme was incubated for one hour. The
assay mixture contained 0.1 mM NH^ci, 0.5 mM ATP and
imidazole-HCl buffer (pH 7.0). Experimental conditions
were as described previously in Figure 11.
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Treatment of Some of the Previous Data in Terms of the 
Hill Equation
The previous sigmoidal curves (Figure 12) in the 
presence and in the absence of SDS were replotted in terms 
of the Hill equation (Figure 13).
lo9 yV_v = n log[F6P] - log Km (3)
max
where,
v = velocity of PFK at a particular FGP concentration
maximum velocity, obtained experimentally
K = Michaelis constant, obtained from the inter- m
ception with the (log ^ - ■ ) axis
vm“v
n = Hill number (the slope of the line) a measure 
of the cooperativity between the subunits
Figure 13 confirmed the previously reached conclusion of 
Figure 12. The Hill coefficient was about the same for 
all of them, i.e., 2.2, 2.1, and 2.2 for control,
2.0x10”^ M SDS and 2.5xl0-  ^M SDS, respectively. This 
indicates that the degree of cooperativity is the same in 
the presence and in the absence of SDS.
The values of the Hill coefficient obtained may seem 
to be low, but they usually vary from 2.0 to 5.4 depending
Figure 13
Replot of PFK activity as a function of [F6P] (data 
from Figure 10) in terms of the Hill equation.
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on the concentration and ratio of ATP to other activators 
present in the system.
Replotting the Inactivation Curve (Figure 5) of PFK as a 
Function of Increasing SDS Concentration in the Presence 
and in the Absence of the Natural Substrate (F6P) in a 
Modified Form of Hill Equation
It has been shown mathematically that some of the 
characterized types of enzyme inhibition are amenable to 
a Hill-type treatment. Thus the logarithm of a function 
of the degree of inhibition bears a linear relationship 
to the logarithm of the inhibitor concentration over a 
wide range. In most of the cases that have been studied, 
the slope of such a line has an integral value indicating 
that exactly one or more inhibitor molecules react 
cooperatively to totally inactivate the enzyme. In other 
cases, the slope does not have an integral value. This is 
mostly due to incomplete allosteric interaction or in­
complete inhibition (Atkinson, 1965 and 1966).
A modified Hill-type equation was derived and 
suggested by Dr. W. L. Mattice to fit the inactivation 
curve of PFK by SDS in the presence and in the absence of 
effectors. This equation was applied to the data obtained 
in presence and in absence of F6P. The suggested equation 
was the following:
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l°g(~ “ 1) = a log [SDS] + log c (4)
where,
v = the velocity in the absence of SDS 
= the velocity in the presence of SDS 
a = the interaction coefficient (the slope, or the 
number of moles per mole of PFK) 
c = constant which can be determined from the 
interception of the line with the ordinate
Figure 14 and 15 are replot of the data of Figure 5 
and the F6P curve of Figure 8 according to Equation (4).
The conclusion from these two plots is that the 
binding of SDS to PFK in the presence and in the absence 
of 1 mM F6P in the incubation mixture is cooperative.
Also, 7.3+1.0 moles and 7.1+0.6 moles of SDS are bound per 
mole of PFK in the presence and in the absence of the 
substrate, respectively. These values for a were cal­
culated by using unweighted least-squares according to 
Fraser and Suzuki (1973).
The Difference Spectra of PFK as a Function of Increasing 
SDS Concentration
Figures 3 and 4 show the tandem double-compartment 
cells, the composition of the different solutions, and
Figure 14
Replot of the inactivation curve of PFK as a function 
of SDS concentration (Figure 5), in terms of a modified 
Hill-type equation.
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Figure 15
Replot of the inactivation curve of PFK in presence 
of 1 mM F6P as a function of SDS concentration (Figure 8), 
in terms of a modified Hill-type equation.
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Figure 16
The difference spectra of PFK as a function of 
increasing SDS concentration. Reactants and conditions 
were as previously described under "Materials and Methods".
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the positioning in the Cary 14 cell compartments. The 
difference spectral experiments were carried out at.room 
temperature by titrating the enzyme with increasing 
aliquots of SDS. The difference spectra obtained are 
shown in Figure 16, at 4, 6, 10, 20, and 50 equivalents of 
SDS. There are characteristic changes in the shape, the 
location, and the intensity of the spectra at low SDS 
equivalents (less than 10) and at higher equivalents 
(greater than 10). At low SDS equivalents there exist a 
broad trough between 295 nm and 310 nm, and two peaks with 
maxima at 282.5 nm and 288.7 nm. A broad trough extends 
from 277.5 nm to 236.3 nm, with increasing negative 
intensity along this wavelength range and reaches its 
minimum around 238.7 nm. At higher SDS equivalents (10, 
20, and 50), there is progressive increase in the negative 
intensity and two troughs appear centered at 295 nm and 
286 nm. The negative intensity of the trough near 240 nm 
increased as a function of SDS concentration, with the 
appearance of a shoulder near 260 nm at 20 equivalents of 
SDS.
The Difference Spectra of PFK as a Function of Increasing 
F6P Concentration
Figure 17 depicts the difference spectra of PFK at 
1, 3, 5 mM F6P, and 5 mM F6P plus 50 equivalents of SDS. 
First noted is that the general shape of the spectra was
Figure 17
The difference spectra of PFK as a function of 
increasing F6P concentration and in the presence of 50 
equivalents of SDS. Experimental conditions were as 
described under "Materials and Methods".
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similar in the presence of varying P6P concentration but 
quite different after adding the 50 equivalents of SDS plus 
the 5 mM P6P. Secondly, there was an increase in the 
intensity of the spectrum from 1 to 3 mM F6P and then a 
decrease at 5 mM. Thirdly, there was a peak at 250 nm, 
troughs at 280 nm and 238 nm, and a shoulder around 260 nm 
which was completely abolished after addition of SDS.
Also, the 50 equivalents of SDS produce two troughs at 
286 nm and 295 nm. Reactants and conditions were as 
described in Figure 16 and under "Materials and Methods".
The Ultraviolet Absorption Spectra of the Nucleotide 
Containing Fraction Isolated after Digestion with 
Chymotrypsin
In Figure 16 a trough of an unusual shape and inten­
sity appeared in the short wavelength region between 230 
and 260 nm. Such an absorption in this region is un­
expected from the usual protein components known to absorb 
here. This and other evidence which will be mentioned 
in the discussion led me to a search for a nucleotide or 
oligonucleotide in association with PFK. Consequently, 
a chymotrypsin digestion was carried out on PFK, and the 
product subjected to an ion exchange chromatography. 
Fractions of the effluent were monitored in the ultra­
violet light to locate the fractions containing the 
nucleotide.
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Figure 18 depicts the ultraviolet spectra of the 
fraction containing the nucleotide (or oligonucleotide) in 
neutral, alkaline (pH 11.0), and acidic (pH 1.0) solutions. 
The spectrum is greatly affected by acidic pH, while it is 
approximately the same at neutral and alkaline pH's.
Circular Dichroic Changes of PFK as a Function of 
Increasing SDS Concentration
As previously indicated under "Materials and Methods", 
the CD spectrum of PFK, at 0.02, 0.2, and 1 mg of protein/ 
ml was scanned throughout the aromatic and the peptide 
chain absorption region. The only positive data obtained 
was in the peptide region (240-200 nm) . Consequently, a 
wavelength of 218 nm was used to monitor the change in 
molar ellipticity, [0], as a function of increasing SDS 
equivalents.
Figure 19 shows the change in (0 J of PFK as a result 
of its titration with increasing SDS concentration. 
Experimentally three PFK concentrations and 2, 4, 10, 20, 
30, 50, and 100 equivalents of SDS were used. It is clear 
that the change in the [0] is dependent on the protein 
concentration. This also might indicate that the change 
in the conformation is quite different in each case of 
protein concentration examined. It is difficult to tell 
exactly what kind of conformational changes occur when
Figure 18
Ultraviolet spectrum of the nucleopeptide isolated 
from the chymotrypsin digestion of PFK. The spectrum was 
carried out under acidic, neutral, and alkaline conditions. 
Cary 14 adjusted at 0.5 A°/sec (xlO), 100 A° marker and 
recorder selector at 1.
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Figure 19
Plot of changing ellipticity at 218 nm of PFK (0.02,
0.2, and 1 mg/ml) in 50 mM tris-phosphate buffer (pH 8.0), 
and 1 mM EDTA versus increasing SDS equivalents. The 
baseline signal is substracted from the experimental 
signal to obtain the net signal from which the ellipticities 
[0] are calculated according to Equation (2). The spread 
shown at each point indicates the degree of noise (error 
in the signal).
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comparing them to model systems of a-, 3-, and random coil 
structures.
Figure 20 depicts the effect of SDS on the CD 
spectrum of PFK (0.2 mg/ml) in the presence and in the 
absence of 1 mM F6P. Quite‘obvious here, is the difference in 
the CD spectrum in the presence and in the absence of the 
substrate. In the absence of F6P the [0] decreases to a 
minimum at 30 equivalents of SDS, then increases to a 
maximum at 40 equivalents of SDS followed by another 
decrease. In the presence of F6P the spectrum, as a 
whole, moves in the opposite direction with the sharp 
minimum at 30 equivalents becoming a shallow valley. This 
might indicate that the conformational changes in presence 
of the substrate are completely different and in the 
opposite direction from these in its absence.
i
Figure 20
Plot of changing ellipticity at 218 nm of PFK (0.2 
mg/ml), in the presence and in the absence of 1 mM F6P 
versus increasing SDS concentrations. Experimental con­
ditions were as described under "Materials and Methods" 
and as in Figure 19.
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IV. DISCUSSION
In this study, the anionic detergent SDS has been 
used to gain an insight into the dependence of the activity 
of PFK on its state of aggregation and the nature of the 
forces that hold its subunits together in the native 
oligomeric form. Moreover, the techniques of UV difference 
spectroscopy and circular dichroism were applied to 
investigate the conformational changes induced by SDS in 
presence and in absence of the natural substrate (F6P) of 
this enzyme.
The data reported here shed some light on the nature 
of SDS binding to PFK. It appears that some of the SDS 
molecules bind at a fast rate, within the first ten 
minutes, and the remainder at a slower rate, until the re­
action reaches equilibrium within approximately two hours. 
Treatment of the results of Figure 5 and 8 in the presence 
and in the absence of 1 mM F6P with a Hill-type equation 
indicated that the inactivation of PFK was caused by a 
sigmoidal type inhibition and approximately 7 moles of SDS 
were bound per mole of PFK. Also, treatment of the 
sigmoidal curves of Figure 12 with the Hill equation 
confirmed the same kind of sigmoidal inhibition. The SDS 
binding to PFK appears to be cooperative. From these 
data, the binding of the first few molecules of SDS 
induces a slight conformational change, which then
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facilitates the binding of subsequent ligands. This kind 
of binding was observed by many investigators (Ray et al.., 
1966, Reynolds et al.,1967).
There was no effect by SDS binding at low or high SDS 
concentration, on the sigmoidal kinetics of PFK and the 
cooperativity between its subunits was apparently retained.
While these results show that SDS at low concentration 
activates PFK, a loss of activity begins to appear at 
higher concentrations until complete inhibition is reached, 
in the presence or in the absence of effectors. This kind 
of behavior has been observed with many other enzymes as 
indicated in the "Introduction". Of particular interest 
is the activation of dihydrofolate reductase up to twice 
the control value by increasing urea concentrations 
(Reyes and Huennekens, 1967). Also, the slight inhibition 
followed by a large increase in the activity of chymo­
trypsin (using n-acetyl-L-tyrosine ethyl ester as substrate) 
by increasing SDS concentrations (Gaudin and Viswanatha, 
1972) provides a similar example. The observed effect of 
SDS on PFK is in general agreement with these and other 
reports. It seems that a low concentration of SDS brings 
about a conformational change indicative of an increase in 
enzymatic activity. At higher concentration, however, 
inhibition results.
Recently, the kinetic characteristics of PFK have 
been studied extensively. One of these allosteric
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features of PFK is the effect of the adenine nucleotides 
on its activity. The ATP inhibition and activation of 
the enzyme was shown by Parmeggiani and Bowman (1963) , and 
Uyeda and Racker (1965) to depend on its concentration as 
well as on the pH. Another important characteristic of 
PFK is its sigmoidal response to increasing F6P concentra­
tion at relatively low pH (Mansour and Mansour, 1962).
The binding studies on rabbit skeletal muscle and sheep 
heart PFK by Kemp and Krebs (1967), and Loren son andMansDur (1969) 
indicated the presence of a binding site that is highly 
specific for the adenine nucleotides, namely,
AMP, ADP, ATP, and c-AMP. The number of binding sites per 
protomer for AMP, ADP, c-AMP, ATP, F6P, and FDP was found 
to be 1, 1, 1, 3, 2, and 2., respectively. The three 
binding sites of ATP include one catalytic and two 
regulatory sites. The two binding sites each of F6P and 
FDP are two different classes of binding, one of low 
affinity and one of high affinity.
The results presented in Figure 7 and 8 might provide 
a clue as to the nature of the binding sites of these 
different modulators and substrates. It can be seen from 
Figure 7 that all four adenine nucleotides examined induce 
about the same relative conformational change upon binding 
to the regulatory site. They bring about the same relative 
protection against SDS inactivation. Also, this kind of 
behavior seems to be in accordance with results reported
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from other laboratories (Mansour, 1972), which indicate 
that all these nucleotides activate PFK and compete for 
the same regulatory site. It appears that ATP and AMP 
provide about the same protection. c-AMP or MgATP offer 
slightly better protection than either ATP or AMP. ADP 
offers the greatest protective effect against SDS-induced 
inactivation. These relative protective effects of the 
three groups might be explained on the basis of their 
structures and their fit at the regulatory site. ADP 
appears to induce the highest protection as a result of 
having highest affinity for the regulatory site. ATP has 
one phosphate group more and AMP one less than ADP. Thus, 
their affinity for the regulatory site is probably lower 
than that of ADP. Adding Mg to ATP or using c-AMP as 
protectors afforded more protection than in the case of 
ATP alone or AMP, but still less than ADP. Therefore, 
their binding at the regulatory site is probably tighter 
than AMP or ATP alone.
The protection against SDS-induced inactivation by 
F6P# FDP, and 2,5-anhydro-D-mannitol 1-phosphate, as 
shown in Figure 8, is highest with F6P. This is probably 
due to the fact that F6P has the highest affinity, i.e., 
lowest dissociation constant, for PFK as compared to the 
other 2 sugar phosphates. It appears that the existence 
of the hydroxyl group at C-2 of the natural substrate 
makes a difference in the fit at the catalytic site.
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However, increasing 2,5-anhydro-D-mannitol 1-phosphate to 
10 times the original concentration affords more protection, 
but still less than for F6P. This indicates that the 
hydroxyl group at C-2 is not critical for activity. FDP 
at the same concentration as F6P offers no protection 
against the inactivation of PFK. This is probably due to 
the low affinity of PFK for FDP or because of its binding 
at a specific site different from that of the adenine 
nucleotide or the F6P sites. The possibility that FDP 
binds at a site different from that of F6P was shown to 
exist by Setlow and Mansour (1972) in their binding 
studies with PFK.
As mentioned in the "Introduction", citrate is a 
potent competitive inhibitor for PFK. It is assumed by 
Kemp and Krebs (1967), and Lorenson and Mansour (1969) 
that it exerts its effect either by binding the same 
regulatory site as ATP or nearby this site. The results 
of Figure 10 indicated that citrate did not afford the 
kind of protection expected from binding to the adenine 
nucleotide regulatory site. This suggests that citrate 
binds a site different from the nucleotide site.
Arabinose 5-phosphate apparently competes with F6P for 
the catalytic site, since it provided the same kind of 
protection as in the case of F6P. Besides this, there is 
a similarity in their structures? the difference being 
the lack of a hydroxymethylene group in the arabinose
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5-phosphate molecule corresponding to the c-1 in F6P 
(Figure 26, Section Two).
Difference spectroscopy and CD measurements
An interesting piece of information was obtained from 
the difference spectral studies of Figure 16 and 17. This 
information may help in revealing the nature of the binding 
sites of SDS and the changes in the environment of some 
of the aromatic residues of PFK.
The absorption of light between 270 and 310 nm by 
proteins is almost all due to tyrosyl and tryptophyl 
residues (Wetlaufer, 1962) . In the short wavelength region 
near 230 nm, several components such as aromatic amino 
acid residues, histidine, cysteine, and peptide groups 
contribute to the absorption. This renders this region 
less meaningful than the aromatic region.
The results in Figure 16 indicate that the detergent 
produces characteristic difference spectra even at low 
concentrations (4 and 6 equivalents). This detergent 
effect is characterized by a slight depression between 295 
and 310 nm, which becomes deeper as the number of equiva­
lents increase. This depression may be attributed to an 
alteration in the environment of the tryptophan and 
tyrosine residues, mostly caused by increased solvation 
(Donovan, 1969). The two peaks at 282.5 and 288.7 nm are 
characteristic of tyrosine red shift, with some contribution
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by tryptophan. This red shift might be a result of 
shielding of the chromophore by the hydrophobic tail of 
the detergent (Steinhardt et al. 1972). The trough at 
295 nm is very characteristic of the blue shift of the 
tryptophan residue incident to transfer from apolar to 
more polar environment. The blue shifted trough at 286.5 
nm contains components due to both tryptophan and tyrosine.
The region from 260 to 275 nm contains elements con­
tributed mostly by phenylalanine. This contribution was 
shown by Herskovits (1967) to be slight and can be 
neglected. Thus it seems feasible that there is another 
unknown component different from phenylalanine absorbs in 
this region.
The trough near 240 nm increases sharply in intensity 
and broadens over a wide range of wavelength as the number 
of SDS equivalents increases. The change of absorption 
of the peptide bonds, either because of a change in their 
geometrical arrangement or because of an environmental 
change, would not produce such an unusual trough. Their 
absorption was shown by Polet and Steinhardt (1968) to be 
sharp, narrow, and near 230 nm. The CD experiment (Figure 
19) proved the presence of a conformational change in the 
peptide backbone as a result of SDS binding under the 
same experimental conditions as the difference spectroscopy 
experiment. Consequently, if we assume that all the 
components are contributing to the absorption in this
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region, they are still not enough to explain this unusual 
trough. The amino acid analysis performed in three 
different laboratories (Parmeggiani et al. 1966; Paetkau 
et al. 1968 ; Tarui et al^ . 1972) did not account for the 
total weight of PFK. This discrepancy led Bloxham and 
Lardy (1973) to suggest that the presence of other 
components contribute to the total structure of PFK.
This suggestion was supported by a series of reports by a 
Russian group (Volodina etaL, 1971,1972; Pechenova etaL, 1973) vho prcwided 
evidence for the existence of a nucleotide tightly bound 
to PFK. All these observations lead me to believe that 
some kind of nucleotide or oligonucleotide is contributing 
to this trough (230-260 nm) together with the other com­
ponents. Further evidence for the presence of a nucleo­
tide was obtained by carrying out the chymotrypsin diges­
tion, applying the product to ion exchange column and 
monitoring the effluent fractions in the UV region as 
shown in Figure 18. At the time this dissertation was 
being written, detailed information and characterization 
of this nucleotide were still being carried out by a group 
under the direction of Dr. E. S. Younathan.
The protection against SDS-induced inactivation of PFK 
by different effectors may be interpreted in the light of 
the results obtained by the difference spectra (Figure 17) 
and the CD spectra (Figure 20). The binding of the 
substrate by PFK induces changes in the environment of
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some of the chromophOres (Figure 17). The spectral 
changes observed in the presence of the substrate were 
different from those observed in its absence. In addition, 
the CD spectrum (Figure 20) indicates a change in the 
conformation of PFK in the presence of F6P opposite to the 
direction of the change induced by SDS alone. Thus, the 
changes in the chromophores environment and 
in the conformation of the enzyme, as a result of the 
substrate binding, might explain its protective effect 
against SDS action. It appears from Figure 19 that the 
effect of SDS on PFK conformation might depend on the 
protein concentration and its state of aggregation. Con­
sequently, it would be difficult to correlate these data 
with the corresponding data in the kinetic work. This is 
because the amount of protein used in the kinetic work is 
much less than that used in the CD and the difference 
spectroscopy experiments. However, the CD and the 
difference spectroscopy studies gave some information 
concerning the conformational changes brought about in 
PFK upon binding of different modulators and SDS to the 
enzyme.
SECTION TWO: The Specificity
of Fructose 6-phosphate Site
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I. INTRODUCTION AND OBJECTIVES
The interaction between an enzyme and its substrate 
can best be understood if the three-dimensional structures 
of both are known. In the case of carbohydrate substrates, 
they usually exist in solution as equilibrium mixtures of 
several forms. Determining the configuration of the sub­
strate that is accepted by the enzyme is necessary to 
reveal the structural relationship between them.
The role of phosphofructokinase in the regulation of 
glycolysis is well documented (Bloxham and Lardy, 1973) .
The structural requirements for the substrate seem to be 
much more rigid than those for an activator, an inhibitor 
or a deinhibitor (Mansour, 1972). Only D-fructose 6- 
phosphate acts as a substrate very efficiently, and little 
is known of the exact structural specificity of this site 
of PFK. A detailed knowledge of the substrate specificity 
is an important primary step in the delineation of a 
stereochemical model of the active site and the mechanism 
of action of the enzyme.
In aqueous solution aide- and ketohexoses and their 
derivatives exist as cyclic configurations in rapid 
equilibrium via acyclic ones (Pigman and Isbell, 1968).
A knowledge of the equilibrium distribution of these 
tautomeric forms is a prerequisite of the tautomeric and 
anomeric specificity of the enzymatic system.
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Several inconclusive reports by Avigad et al. (1970), 
Gray and Barker (1970), and Sewenson and Barker (1971) 
have failed to assess quantitatively the contributions of 
the D-fructose 6-phosphate tautomeric forms using different 
techniques, namely, UV, ORD, CD, IR, and NMR.
13Koerner et al. (1973) using Fourier transform C 
magnetic resonance spectroscopy succeeded in determining 
quantitatively the percentage of each forms of the sub­
strate (D-fructose 6-phosphate) and the product (D- 
fructose 1,6-diphosphate). They also suggested that the 
B-anomer might be the form involved in the enzyme-substrate 
complex. The same results they obtained (-20%a-,
*80%$-, and less than 1.5% keto or hydrated keto form) 
were confirmed by BenkoVic et al. (1973), and Wurster 
and Hess (1974) using other independent techniques (NMR 
and stopped flow kinetic measurements).
The objective of this study was to investigate the 
tautomeric, the anomeric, and some other related 
aspects of the structural specificity of the D-fructose 
6-phosphate site of PFK.
As mentioned previously little was known about the 
substrate (D-fructose 6-phosphate) specificity, and little 
work has been done to investigate this point. As with the 
case of determining the tautomeric forms of D-fructose
6-phosphate, our laboratory was the first to determine 
unequivocally the substrate specificity of PFK. A
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preliminary report (Koerner et al., 1973-A) and a paper 
(Koerner et al., 1974), which include some of the work 
presented here, have been published.
The first report investigating the phosphoryl acceptor 
specificity was by Totten and Lardy (1949). They indicated 
that D-tagatose 6-phosphate was phosphorylated by PPK at 
about 50% the rate of D-fructose 6-phosphate. Sedoheptulose
7-phosphate was also used slowly at reasonable concentra­
tion.
Later Lardy (1962) reported that L-sorbose 1-phosphate, 
L-sorbose 6-phosphate, and D-ribose 5-phosphate were not 
detectably phosphorylated by PFK.
D-glucose 1-phosphate was shown by Eyer et al. (1971) 
to act as an alternate substrate for PFK. The phosphoryla­
tion rate was found to be 0.7% that of D-fructose 6- 
phosphate.
More recently Uyeda (1972) has shown that rabbit 
muscle PFK catalyzed the phosphorylation of D-fructose 
1-phosphate at 5% of the rate of D-fructose 6-phosphate. 
Also, D-fructose 1-phosphate was found to be a competitive 
inhibitor of the phosphorylation of D-fructose 6-phosphate 
indicating that both compete for the same active site.
Concerning the anomeric specificity of PFK, Benkovic 
et al. (1972) reported that the 0-D-fructose 6-phosphate 
was rapidly used by PFK. Whether the a-anomer was utilized 
directly or only after mutarotation to the 0-form, was not
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established. Bloxham and Lardy (1973) using space-filling 
models of a-D-fructose 1-phosphate as an analogue of 8-D- 
fructose 6-phosphate and L-sorbose 1-phosphate as an 
analogue of a-D-fructose 6-phosphate confirmed Benkovic 
et al.1s report.
It was suggested in two consecutive reports by Bar- 
Tana and Cleland (1974) that PFK is specific both for the
8-anomers of D-fructose 6-phosphate and D-fructose 1,6- 
diphosphate and for the D-configuration at C-5. This 
suggestion was based on the high activity of the 2,5- 
anhydro-D-mannitol 1-phosphate and the failure of L- 
sorbose 6-phosphate or 2,5-anhydro D-glucitol 6-phosphate 
to act as substrates. They also showed that the affinity 
for 1-deoxyfructose 6-phosphate is the same as D-fructose 
6-phosphate in presence of MgATP, while it is 30-fold less 
in absence of MgATP. This indicated that the C-l hydroxyl 
group is important for binding.
Replacement of the phosphoryl moiety of D-fructose 6-
phosphate by a sulfuryl group was found by Martensen and
Mansour (1974) to serve as a substrate for the heart PFK.
The apparent K and V were found to be of approximately m max
100 fold and 0.03 that of D-fructose 6-phosphate, 
respectively.
It would be helpful to make some terms used in this 
section clear, such as the following:
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1) Absolute configuration (D,L): All optically
active compounds may be related stereochemically to a 
single parent compound that has been arbitrarily chosen to 
serve as a standard of reference for stereoisomers, which 
is the 3-carbon sugar glyceraldehyde.
2) Tautomers: The cyclic-acyclic isomers of a
reducing sugar.
3) Epimers; Two sugars that differ in the configura­
tion around one specific asymmetric carbon atom only.
4) Anomers: The two distinguishable isomers, 
namely, the a- and 8-forms, which result from the creation 
of a new asymmetric carbon upon the formation of the 
hemiacetal linkage (i.e., in the cyclization process) of 
aldoses and ketoses. This new asymmetric carbon is C-l
in glucopyranose and C-2 in fructofuranose forms.
II. MATERIALS AND METHODS
Materials
D-Mannitol, dihydroxyacetone, D-xylulose 5-phosphate, 
D-mannitol 1-phosphate, D-glucitol 6-phosphate, D-ribose 
5-phosphate, 2-deoxy-D-ribose 5-phosphate, D-arabinose
5-phosphate, D-fructose 1-phosphate, and D-fructose were 
purchased from Sigma Chemical Company.
1,6-Hexanediol monophosphate, 1,5-pentanediol mono­
phosphate, diethylene glycol monophosphate, (2-tetra- 
hydrofuryl)-methanol phosphate, 2,5-anhydro-D-mannonate
6-phosphate, D-psicose 6-phosphate, L-sorbose 6-phosphate,
2,5-anhydro-D-mannose 6-phosphate, (a+3)-methyl-D- 
fructofuranoside 6-phosphate, 1,4-anhydro-D-arabinitol 5- 
phosphate, 2,5-anhydro-D-mannitol 1-phosphate, 2,5- 
anhydro-D-glucitol 6-phosphate, 6-bromo-6-deoxy-2,5- 
anhydro-D-mannitol 1-phosphate, D-tagatose 6-phosphate, and 
D-tagatose 6-sulfate were synthesized in our laboratory
by Mr. T. A. W. Koerner, Jr. and Mr. R. J. Voll under the 
direction of Dr. E. S. Younathan.
Preparation of the enzyme and all other reagents used 
were the same as mentioned in Section One.
PFK Assay
The assay procedure was the same as described in 
Section One under "Materials and Methods" (Figure 1A).
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The procedure depends on assay of the ADP produce by 
coupling to NADH oxidation via pyruvate kinase and lactic 
dehydrogenase. This procedure allows us to test many 
analogues, without concern about the acceptance of the 
product by aldolase in the method of Ling et al^ . (1966) .
The reaction was initiated by the addition of F6P or its 
analogues at the concentrations indicated in the Figures 
under "Results". Bovine serum albumin (0.01%) was added 
to the dilution mixture of PFK to increase the enzyme 
stability.
Data Processing
Kinetic data were depicted as a Lineweaver and Burk 
(1934) plots for the substrate analogues and as a Dixon 
(1953) plots for the inhibitors. The kinetic constants 
were calculated from the best fitting regression lines 
generated through an iterative least squares analysis of 
the data. This analysis was programmed in Fortran using 
a slight modification of the program recommended by Cleland 
(1967) and performed on an IBM 360 computer. The pro­
gramming was carried out by Mr. R. J. Voll.
III. RESULTS
For some time, little was known about the relative 
amounts of the various forms of D-fructose 6-phosphate in 
solution and under the experimental conditions of PFK 
assay. These isomers are two cyclic furanose forms (a- 
and 0-anomers) and acyclic keto and hydrated keto forms as 
shown in Figure 21. Our laboratory made a large contribu­
tion in determining the percentage of each of these forms 
(Koerner et al., 1973). The percentage of these isomers 
was found to be approximately 20%, 80%, and less than 1.5% 
for the a-anomer, the 8-anomer, and the keto or hydrated 
keto forms, respectively.
Figure 21 shows the two readily interconvertable 
ring-chain tautomers available to PFK to act upon. To 
determine the tautomeric specificity of PFK, several 
analogues of the ring and the open chains were tested as 
an alternate substrate for PFK (Figure 22). These analogues 
are locked in one conformation to eliminate the possibility 
of tautomerism. (a+0) Methyl-D-fructofuranoside 6- 
phosphate and (2-tetrahydrofuryl) methanol phosphate were 
tested as analogues of the cyclic furanose tautomer. D- 
mannitol, D-mannitol 1-phosphate, D-glucitol 6-phosphate, 
D-xylulose 5-phosphate, dihydroxyacetone, diethylene 
glycol monophosphate, 1,5-pentanediol monophosphate, and
1,6-hexanediol monophosphate were tested enzymatically as
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Figure 21
The tautomeric and anomeric forms of D-fructose 6- 
phosphate in solution were determined by Koerner et al. 
(1973). The percentage of each was found to be 20%, 80%, 
and less than 1.5% for the a-, 8-, and keto or hydrated 
keto form of D-fructose 6-phosphate, respectively.
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Figure 22
Analogues used to determine the tautomeric specificity
of PFK. All these compounds were tested at a maximum
concentration of 5 mM relative to 1 mM for D-F6P in 1 ml
assay mixture. (a+8) Methyl-D-fructose 6-phosphate was
the only compound that acted as an alternate substrate
for PFK. The K and were 3.8 mM (D-F6P K = 0.043 mM)m max m
and 40% of that of D-F6P, respectively. The assay condi­
tions were as described under "Materials and Methods".
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analogues of the acyclic keto and hydrated keto tautomers. 
Only (a+0) methyl-D-fructofuranoside 6-phosphate displayed 
enzymatic activity as an alternate substrate of D-fructose 
6-phosphate. Its kinetic constants were Km=3.8 mM and 
Vmax = D-fructose 6-phosphate. All other
analogues were tested at a maximum concentration of 5 mM 
and were inactive. This tends to indicate that PFK has 
a tautomeric specificity for the furanose form of D- 
fructose 6-phosphate. The assay procedure was as described 
under "Materials and Methods".
Because of the thermodynamic predominance of the 0-
form in solution of both D-fructose 6-phosphate and D-
fructose 1,6-diphosphate (Koerner et al^ ., 1973), it is
suggested that 8-D-fructose 6-phosphate is the form of
D-fructose 6-phosphate acted upon by PFK. To assess this
point, we tested the two compounds shown in Figure 23 as
alternate substrates or inhibitors of PFK. The first
analogue (2,5-anhydro-D-mannitol 1-phosphate) was tested
as an analogue of the 8-anomer. The second one (2,5-
anhydro-D-glucitol 6-phosphate) was tested as an analogue
of the a-anomer. The only difference between the first
and the second one is the configuration around the one
carbon that corresponds to C-2 of D-fructose 6-phosphate.
The 8-anomer analogue was found to be a good alternate
substrate for PFK with a K - 0.41 mM and a V _  = 87% ofm max
that of D-fructose 6-phosphate as depicted in Figure 24.
Figure 23
Analogues used to determine the anomeric (C-2) 
specificity of PFK. 2,5-anhydro-D-mannitol 1-phosphate 
and 2,5-anhydro-D-glucitol 6-phosphate were tested as 
analogues of the 8-anomer and the a-anomer, respectively. 
The first acted as an alternate substrate (Figure 24), 
while the second as a competitive inhibitor (Figure 25).
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Figure 24
Lineweaver-Burk plot of the initial rates of 
phosphorylation of D-fructose 6-phosphate and 2,5-anhydro- 
D-mannitol 1-phosphate as a function of substrate con­
centration. The kinetic constants (K and V ) are asm max
shown in the Figure together with that of D-fructose 6- 
phosphate. Assay conditions are as described under 
"Materials and Methods".
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However, the a-anomer analogue was a competitive inhibitor 
of PFK with a = 0.34 mM as shown in Figure 25. These 
results strongly suggest that PFK binds both the a- and 
3-anomers of D-fructose 6-phosphate, but phosphorylates 
only the 6-form.
Having determined the tautomeric and thie anomeric 
(C-2) specificity of D-fructose 6-phosphate, a set of 
analogues that represent the systematic configurational 
permutations of the C-l, C-3, C-4, and C-5 positions.of 
D-fructose 6-phosphate were tested. This study was 
intended to gain information about the configurational 
requirements at these carbons of the substrate.
Figure 26 shows a series of analogues in which 
functionality was progressively removed from fJ-D-fructose 
6-phosphate. Removing the C-l hydroxymethylene functional 
group resulted in a compound (D-arabinose 5-phosphate) that 
acted as an inhibitor and therefore was bound to the 
enzyme. Removing the C-l hydroxyl group only resulted in 
a compound (l-deoxy-3-D-fructose 6-phosphate) that acted 
as a competitive inhibitor or a very poor substrate. How­
ever, removing both the C-l hydroxymethylene, and the C-2 
hydroxyl resulted in a compound (1,4-anhydro-D-arabinitol
5-phosphate) that had no activity. Another series of 
compounds at the bottom of Figure 26 represents the 
transformation of the C-l hydroxyl of 2,5-anhydro-D- 
mannitol 1-phosphate to an aldehyde group, a carboxylic
Figure 25
Dixon plot of the competitive inhibition of 
phosphorylation of D-fructose 6-phosphate by 2,5-anhydro- 
D-glucitol 6-phosphate. Two fixed concentrations (0.023 
mM and 0.046 mM) of D-fructose 6-phosphate were used in 
the assay mixture. The for 2,5-anhydro-D-glucitol 6- 
phosphate was found to be 0.34+0.07 mM. The assay 
conditions are as described under "Materials and Methods".
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The three analogues shown on the middle line of this 
figure were used to determine the C-l specificity of PFK. 
D-arabinose 5-phosphate was found to act as a good 
competitive inhibitor (K^ = 0.93+0.05 mM), whereas, 1,4- 
anhydro-D-arabinitol 5-phosphate was inactive. The bottom 
row of the Figure depicts analogues that resulted from 
transforming the C-l hydroxyl of 2,5-anhydro-D-mannitol 1- 
phosphate to a carboxylic group, aldehyde group, and a 
bromine group. These three analogues were inactive. 
Maximum concentration for any of these analogues in the 
assay mixture was 20 mM. Assay conditions are as 
described under "Materials and Methods".
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group or bromine group. These substitutions at the O l  
hydroxyl led to the formation of completely inactive 
compounds. It should be noted that the analogue 1-deoxy- 
0-D-fructose 6-phosphate was shown to be a competitive 
inhibitor by Bar-Tana and Cleland (1974). The maximum 
concentration used in the assay mixture for any of these 
compounds was 20 mM.
As demonstrated in Figure 26, D-arabinose 5-phosphate 
was found to be a competitive inhibitor of PFK. Figure 27 
shows the Dixon plot of the competitive inhibition of PFK 
by D-arabinose 5-phosphate. Assay conditions were as 
described under "Materials and Methods”. D-fructose 6- 
phosphate concentrations used were 0.023 mM, 0.046 mM, 
and 0.092 mM. The K^ for this analogue was found to be 
0.93+0.05 mM.
The analogues shown in Figure 28 were used to deter­
mine the importance of the C-3 hydroxyl for the binding 
of sugar phosphate to the D-fructose 6-phosphate site. 
D-Psicofuranose 6-phosphate is an analogue identical with 
D-fructose 6-phosphate except for the reversal of the con­
figuration around C-3. This analogue was found to be a 
substrate for PFK (Figure 29). However, it had a Km two 
orders of magnitude higher than the Km for D-fructose 6- 
phosphate. This indicates that PFK has a poor affinity 
for D-psicose 6-phosphate. The other two analogues, 
namely, D-ribofuranose 5-phosphate and 2-deoxy-D-ribofuranose
Figure 27
Dixon plot for the competitive inhibition of 
phosphorylation of D-fructose 6-phosphate by D-arabinose
5-phosphate. Three lines are shown corresponding to 
three fixed concentrations (0.023 mM, 0.046 mM, and 0.092 
mM) of D-fructose 6-phosphate in the assay mixture.
A = 0.93+0.05 mM was found for the inhibitor. Assay 
conditions are as described under "Materials and Methods".
108
109
[FRUCTOSE 6-P
0.023 mM
0.046 mM
K.= 0.93 ±005 mM
0.092 mM
|/XRABIN0SE 5 -rf ,mM
Figure 28
Analogues used to determine the C-3 specificity of 
PFK. 0-D-Psicose 6-phosphate was found to act as a 
substrate. Its kinetic constants are shown in Figure 29. 
The only difference between this analogue and D-fructose 
6-phosphate is that the configuration around C-3 is 
reversed. The other two analogues shown in this Figure 
resulted from either removal or changing the configura­
tion of C-2 hydroxyl of D-arabinose 5-phosphate. Both 
compounds were inactive. Maximum concentration used in 
the assay of these analogues was 10 mM in 1 ml assay 
mixture. Assay conditions were as described previously 
under "Materials and Methods".
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5-P are analogues of D-arabinose 5-phosphate, a competitive 
inhibitor of PFK (Figure 27). Removing the C-2 hydroxyl 
of D-arabinose 5-phosphate or reversing its configuration 
from L to D results in two inactive compounds, namely, 2- 
deoxy-D-ribofuranose 6-phosphate or 0-D-ribofuranose 5- 
phosphate. These changes at C-2 of these analogues 
corresponds to changes at C-3 of D-fructose 6-phosphate. 
This indicates that both the presence and the configuration 
of the C-3 hydroxyl group is essential for binding and 
appreciable substrate phosphorylation.
Figure 29 depicts the Lineweaver-Burk plot of the 
initial rates of phosphorylation of D-fructose 6-phosphate 
and D-psicofuranose 6-phosphate as a function of substrate 
concentration. D-Psicofuranose 6-phosphate acted as a 
substrate with km = 3.0+1.0 mM (D-fructose 6-phosphate 
= 0.032+0.02 mM) and Vmax approximately 45% that of D- 
fructose 6-phosphate. Assay conditions were as described 
under "Materials and Methods".
The two analogues represented in Figure 30 were used
to study the effect of reversing the configuration
(epimerisation) around C-4 and C-5 of D-fructose 6-
phosphate. D-Tagatose 6-phosphate, the C-4
epimer of D-fructose 6-phosphate, was found to be a good
substrate for PFK. Its kinetic constants K , V werem' max
found to be approximately equal to these of D-fructose 6- 
phosphate within the experimental error. On the other
Figure 29
Lineweaver-Burk plot of the initial rates of 
phosphorylation of D-fructose 6-phosphate and D-psicose 
6-phosphate as a function of substrate concentration. The 
kinetic constants for this alternate substrate and D- 
fructose 6-phosphate are shown in the Figure. Assay 
conditions are as described under "Materials and Methods".
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Figure 30
Analogues used to determine the C-4 and C-5 
specificity of PFK. D-Tagatose 6-phosphate acted as a 
good substrate (Figure 31) for PFK, while a-L-sorbose 
6-phosphate acted as a poor substrate. The configuration 
of the functional groups around C-4 and C-5 of these two 
analogues are reversed with respect to the corresponding 
ones of D-fructose 6-phosphate. Maximum concentration 
used of a-L-sorbose 6-phosphate in the assay mixture 
was 25 mM. Assay conditions are as described in Figure 
29.
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hand, L-sorbose 6-phosphate, the C-5 epimer was found to
be a poor substrate. It has a K = 11.0 mM and V = 15%m max
that of D-fructose 6-phosphate. Maximum concentration used
in its assay was 25 mM.
Figure 31 illustates the Lineweaver-Burk plot of the
initial rates of D-fructose 6-phosphate and D-tagatose
6-phosphate as a function of substrate concentration. Km
and V for D-fructose 6-phosphate were 0.043+0.009 mM max —
and 138+7 p moles/min/mg. protein, respectively; while those
of D-tagatose 6-phosphate were 0.054+0.009 mM and 144+7
Vi moles/min/mg. protein, respectively. Assay conditions
were as described under "Materials and Methods".
Figure 32 depicts 5 compounds used to determine the
effect of the net charge and the importance of the
phosphate group of the substrate on PFK activity. Four
of these analogues were tested as alternate substrates
or inhibitors for PFK. The fifth one (D-fructose 6-
sulfate) was found by Martensen and Mansour (1974) to act
as an alternate substrate. The apparent K and V forrr m max
the latter compound were of approximately 100 fold and 0.03 
that of D-fructose 6-phosphate, respectively. D-Tagatose
6-sulfate was found to act as a poor substrate at a 
maximum concentration of 10 mM. These results indicate 
that the replacement of the phosphoryl moiety by a sulfuryl 
group does not abolish their abilities to serve as 
alternate substrates for PFK. Removal of the phosphate
Figure 31
Lineweaver-Burk plot of the initial rates of 
phosphorylation of D-fructose 6-phosphate and D-tagatose
6-phosphate as a function of substrate concentration.
The kinetic constants for this alternate substrate and 
D-fructose 6-phosphate are shown in the Figure. Assay 
conditions are as described under "Material and Methods."
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Analogues used to determine the effect of the net 
charge of the substrate on PFK activity. All these 
compounds were tested in our laboratory, except D- 
fructose 6-sulfate. This compound was shown in the 
Figure for comparison. It was found to be an alternate 
substrate by Nartensen and Mansour (1974). 2,5-Anhydro 
D-mannitol and D-fructose were found to be inactive, 
while the other two acted as poor substrates. Maximum 
concentration used for these analogues in the assay 
mixture was about 20 mM. Assay conditions are as 
described under "Materials and Methods."
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groups from D-fructose 6-phosphate and 2,5-anhydro-D- 
mannitol 1-phosphate produces two inactive compounds, 
namely, D-fructose and 2,5-anhydro-D-mannitol, respectively. 
This indicates that the presence of a phosphate or sulfate 
group on C-6 of D-fructofuranose is essential. Transfering 
the phosphate group from C-6 to C-l produces a compound 
(D-fructose 1-phosphate) which acts as a poor substrate.
All these compounds were tested at a maximum concentration 
of 20 mM. The assay conditions were as described previously 
under "Materials and Methods".
IV. DISCUSSION
Phosphofructokinase is considered as the key regulatory 
enzyme of glycolysis (Bloxham and Lardy, 1973)• Our 
research team has Sought cooperatively to delineate the 
mechanism of action of this important enzyme. As a pre­
requisite to elucidate this mechanism, the specificity of 
the D-fructose 6-phosphate site was determined. One of 
the chosen means to approach this aim, was.to test the 
activity of D-fructose 6-phosphate analogues as alternate 
substrates or inhibitors for PFK. Many of these analogues 
are locked in a cyclic or acyclic form i.e., incapable of 
tautomerization. In addition, most of the cyclic forms, 
according to its acceptance by PFK, probably exist to a 
large extent in solution in the 0-furanose form. Deter­
mining the exact percentages of these cyclic analogue 
forms is still going on in our laboratory.
Having determined the percentage of D-fructose 6- 
phosphate forms in solution by Koerner et al. (1973), the 
thermodynamic predominance of the 0-form of the substrate 
and the product suggested that the 0-form was the one 
acted upon by PFK. This suggestion was strongly supported 
by testing the cyclic analogues, namely, (,a+0) methyl-D- 
fructofuranoside 6-phosphate and (2-tetrahydrofuryl) 
methanol phosphate as analogues of the cyclic furanose 
tautomer. Also, the different acyclic forms shown in
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Figure 22 as analogues of the open keto and hydrated keto 
forms. It is noticeable that the acyclic analogues have 
most of the structural features of the acyclic open chain 
tautomers of D-fructose 6-phosphate. For example, 
dihydroxyacetone was chosen as a good analogue, by assuming 
that the carbonyl group of the open chain is essential for 
binding. Also, D-mannitol 1-phosphate and D-glucitol 6- 
phosphate were used as good analogues if we assume that the 
configuration of the hydroxyl groups and the negative 
charges of the phosphate residue in the open forms are 
essential for binding. All these analogues were inactive 
as alternate substrates or inhibitors of PFK. On the other 
hand, (a+B) methyl-D-fructofuranoside 6-phosphate acted 
as an alternate substrate. This indicates that PFK has a . 
tautomeric specificity for the furanose form of D-fructose 
6-phosphate. The next step was to determine if the enzyme 
possessed a specificity for either the a- or the B-anomer 
of this furanose form.
Two analogues of the a- and the B-anomers of the
furanose form of D-fructose 6-phosphate were tested
(Figure 23). 2,5-Anhydro-D-mannitol 1-phosphate, an
analogue of the B-form was found to be a good alternate
substrate for PFK with a K = 0.41 mM and a V = 87% ofm max
that of D-fructose 6-phosphate. 2,5-Anhydro-D-glucitol 
6-phosphate, an analogue of the a-form, was found to be an 
effective competitive inhibitor of PFK with a k^ = 0.34 mM.
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The close similarity of and indicates that the 
enzyme has about equal affinity for both compounds. The 
only difference between the two analogues is the configura­
tion around C-2 that corresponds to the anomeric carbon 
of D-fructose 6-phosphate. Apparently the shift from the 
3-form to the a-form puts the -CH2OH group in a position 
unfavorable for its phosphorylation. These results 
strongly suggest that the enzyme binds both a- and 3-forms, 
phosphorylates the 3-form only, and the C-2 hydroxyl of 
the furanose form is not essential for activity. The 
acceptance of the 3-form by the enzyme has recently been 
substantiated by the fast-flow kinetic work of Wurster 
and Hess (1974).
To explore further the specificity of the 3-D- 
fructose 6-phosphate site, we set out first to determine 
the C-l specificity. The analogues represented in Figure 
26 were used for this purpose. These compounds differ 
from 3-D-fructose 6-phosphate or 2 ,5-anhydro-D-mannitol 1- 
phosphate (alternate substrate) in the lack or change in 
configuration of the one carbon that corresponds to C-l 
of 3-D-fructose 6-phosphate. One of these analogues 
namely, l-deoxy-3-D-fructofuranose 6-phosphate was shown 
to be a good inhibitor by Bar-Tana and Cleland (1974) .
The fact that 3-D-arabinose 5-phosphate (which lacks the 
-CHjOH relative to C-l of D-fructose 6-phosphate) and 1- 
deoxy-3-D-fructofuranose 6-phosphate) are good
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competitive inhibitors of PFK indicates that the C-l
hydroxyl or hydroxymethylene is not essential for binding
although obviously essential for enzymatic activity, i.e.,
for phosphorylation. 1,4-Anhydro-D-arabinitol 5-phosphate
(has neither -CH0OH nor C-2 hydroxyl relative to 6-D- 
1 4
fructose 6-phosphate) was inactive as an alternate sub­
strate or inhibitor. This indicates that C-2 hydroxyl is 
important in binding. This conclusion appears to contra­
dict our finding that 2,5-anhydro-D-mannitol 1-phosphate 
(which lacks the OH group on the carbon that corresponds 
to C-2 on D-fructose 6-phosphate) is a good substrate for 
PFK. However, this apparent contradiction can be 
resolved by concluding that an -OH, either on C-l or on 
C-2 has to be present in the sugar phosphate for binding 
PFK. The series of compounds at the bottom of Figure 26 
were enzymatically inactive. This suggests that either 
C-l or C-2 hydroxyl most probably is involved in hydrogen- 
bond formation with the enzyme.
In determining the importance of the C-3 hydroxyl 
in binding, three compounds were used as demonstrated in 
Figure 28. D-Ribose 5-phosphate (has a reversed configura­
tion of C-3 hydroxyl and no -CH,OH relative to D-fructose
1 *
6-phosphate), and 2-deoxy-&-D-ribose 5-phosphate (lacks
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C-3 hydroxyl and -CH^OH relative to D-fructose 6-phosphate),
are analogues of D-arabinose 5-phosphate. D-Psicose 6-
phosphate is an epimer of B-D-fructose 6-phosphate (has a
reversed configuration of C-3 hydroxyl relative to D-
fructose 6-phosphate). D-Psicose 6-phosphate was the only
sugar phosphate to act as an alternate substrate with Km =
3.0+1.0 mM and V '= 46% that of D-fructose. 6-phosphate.— max
It seems feasible to conclude that reversal of the configurer 
tion around C-3 resulted in retention of some activity.
This would suggest that the presence and the configuration 
of the C-3 hydroxyl is essential for tight substrate 
binding and maximal catalytic activity.
D-Tagatose 6-phosphate and a-L-sorbose 6-phosphate 
are two epimeric isomers of D-fructose 6-phosphate. Their 
structures compared to B-D-fructose 6-phosphate are given 
in Figure 30. The configuration in these two epimers is 
reversed around carbons number 4 and 5, respectively.
These two analogues were chosen to study the effect of 
such epimerization on their affinity for PFK. D-Tagatose 
6-phosphate, the C-4 epimer, was found to act as an 
exceedingly good alternate substrate for PFK? whereas, 
L-sorbose 6-phosphate, the C-5 epimer, was found to be a 
very poor alternate substrate. The kinetic constants 
of D-tagatose 6-phosphate were found to be almost equal 
to those of B-D-fructose 6-phosphate (Figure 31). It 
seems that the configuration around C-4 is of no
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importance; whereas that around C-5 is important for binding 
and catalysis of the reaction. It should be noted that D- 
tagatose 6-phosphate was shown to act as an alternate 
substrate by Totten and Lardy (1949), who did not determine 
its kinetic constants, however.
The charge specificity and its importance were 
investigated by testing the analogues given in Figure 32, 
as alternate substrates or inhibitors. D-Fructose 1- 
phosphate was shown by us and by Uyeda (1972) to act as a 
poor substrate. The B-furanose form of this analogue has 
a structure that is almost superimposed on B-D-fructose 
6-phosphate when rotated 180°. This is why it 
acts as a poor substrate. Replacement of the phosphoryl 
moiety of B-D-fructose 6-phosphate (Martensen and Mansour, 
1974) and that of B-D-tagatose 6-phosphate by a sulfuryl 
group does not abolish their abilities to act as an 
alternate substrates. In addition, the inactivity of D- 
fructose and 2,5-anhydro-D-mannitol would suggest that 
at least one charge has to be present for binding. More­
over, it seems that one charge is not enough for maximal 
activity.
From the above described findings, we can sum up the 
specificity of the D-fructose 6-phosphate site of PFK as 
follows:
1) Rabbit muscle phosphofructokinase binds only the 
furanose tautomer of D-fructose 6-phosphate.
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2) Only the 0-anomer of D-fructose 6-phosphate is 
phosphorylated.
3) Neither the C-l nor the C-2 hydroxyl of D-
1 fructose 6-phosphate is essential for binding. However, 
one of the two must be present and probably forms a 
hydrogen bond with the enzyme.
4) The C-3 hydroxyl must be present and must have an 
L-configuration for significant activity.
5) Neither the presence nor the configuration of the 
C-4 hydroxyl is essential for binding or catalysis.
6) The configuration of C-5 must have the D-type.
7) The C-6 hydroxyl must bear an anionic group, with 
at least one charge for binding.
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APPENDIX I 
TABLE OF ABBREVIATIONS
AMP Adenine monophosphate
ADP Adenine diphosphate
ATP Adenine triphosphate
2,5-ADM 1-P 2,5-Anhydro-D-mannitol 1-phosphate
A5P Arabinose 5-phosphate
Arg Arginine
BSA Bovine serum albumin
C.A. Chemical Abstract
C Centigrade
cm Centimeter(s)
CD Circular dichroism
c-AMP Cyclic 3,5-adenosine monophosphate
cyt c Cytochrome c
DTT Dithiothritol
d mole Decimole
deg degree(s)
DHAP dihydroxyacetone phosphate
EDTA Ethylenediamine tetra acetate
Equiv. Equivalent(s)
F6P D-Fructose 6-phosphate
FDP Fructose 1,6-diphosphate
giA Grams(s)
G3P Glyceraldehyde 3-phosphate
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ot-GDH a-Glycerophosphate dehydrogenase
Hb Hemoglobin
His Histidine
hr. Hour(s)
IR Infrared
K Michaelis constantm
LDH Lactic dehydrogenase
Lys Lysine
yg Microgram(s)
yM Micromolar
y mole Micromole (s)
mg Milligram(s)
ml Milliliter(s)
mm Millimeter(s)
mM Millimolar
M Molar
m wt. Molecular weight
Mb Myoglobin
nm Nanometer
NAD Nicotinamide adenine dinucleotide
NADH Nicotinamide adenine dinucleotide
(reduced form)
NMR Nuclear magnetic resonance
OD. Optical density
ORD Optical rotatory dispersion
P Phosphate
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PEP Phosphoenol pyruvate
PFK Phosphofructokinase
PYR Pyruvate
PK Pyruvate kinase
phe Phenylalanine
SDS Lauryl sodium sulfate (sodium dodecyl sulfate)
TPI Triosephosphate isomerase
Tris-Cl Tris(hydroxymethyl) aminomethane-chloride
Tris-P Tris(hydroxymethyl) aminomethane-phosphate
try Tryptophan
tyr Tyrosine
Uv Ultraviolet
V Velocity
Vmax
Maximum velocity
wt. Weight
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